Skip to content
Aussie8 – Lifestyle
Author:
AbbVie
Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care
September 2, 2026
SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings
September 1, 2026
AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
August 21, 2026
AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support
August 18, 2026
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
August 6, 2026
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
August 5, 2026
AbbVie Reports Second-Quarter 2026 Financial Results
July 31, 2026
JUVÉDERM® Day Returns to U.S. on August 19
July 30, 2026
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
July 29, 2026
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
July 29, 2026
1
2
3
Next Page
→